The use of platensimycin and platencin to fight antibiotic resistance

References

• World Health OrganizationThe Global Burden of disease: 2004 UpdateGenevaWorld Health Organization2008 Available from: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf
   Google Scholar
• World Health OrganizationGlobal Health Risks: mortality and burden of disease attributable to selected major risksGenevaWorld Health Organization2009 Available from: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf
   Google Scholar
• ZinnerSHAntibiotic use: present and futureNew Microbiol200730332132517802919
   PubMed Web of Science ®Google Scholar
• CunhaBAAntibiotic resistanceMed Clin North Am20008461407142911155850
   PubMed Web of Science ®Google Scholar
• MacleanRCHallARPerronGGBucklingAThe evolution of antibiotic resistance: insight into the roles of molecular mechanisms of resistance and treatment contextDiscov Med2010105111211820807471
   PubMed Web of Science ®Google Scholar
• LevySBMarshallBAntibacterial resistance worldwide: causes, challenges and responsesNat Med200410Suppl 12S122S12915577930
   PubMed Web of Science ®Google Scholar
• BushKAntibacterial drug discovery in the 21st centuryClin Microbiol Infect200410Suppl 4101715522035
   PubMed Web of Science ®Google Scholar
• World Health Organization2011/2012 Tuberculosis Global FactsGenevaWorld Health Organization2011 Available from: http://www.who.int/tb/publications/2011/factsheet_tb_2011.pdfAccessed April 16, 2013
   Google Scholar
• StyersDSheehanDJHoganPSahmDFLaboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United StatesAnn Clin Microbiol Antimicrob20065216469106
   PubMedGoogle Scholar
• BorgMAde KrakerMSciclunaEPrevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countriesJ Antimicrob Chemother20076061310131517913724
   PubMed Web of Science ®Google Scholar
• SibandaTOkohAIThe challenges of overcoming antibiotic resistance: plant extracts as potential sources of antimicrobial and resistance modifying agentsAfr J Biotechnol200762528862896
   Google Scholar
• GarciaLSMalariaClin Lab Med20103019312920513543
   PubMed Web of Science ®Google Scholar
• WrightGDQ&A: antibiotic resistance: where does it come from and what can we do about it?BMC Biol2010812320887638
   PubMed Web of Science ®Google Scholar
• RahalJJNovel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter speciesClin Infect Dis200643Suppl 2S95S9916894522
   PubMed Web of Science ®Google Scholar
• StefanovicODStanojevicDDComicLRSynergistic antibacterial activity of Salvia officinalis and Cichorium intybus extracts and antibioticsActa Pol Pharm201269345746322594260
   PubMed Web of Science ®Google Scholar
• KangHKKimHYChaJDSynergistic effects between silibinin and antibiotics on methicillin-resistant Staphylococcus aureus isolated from clinical specimensBiotechnol J20116111397140821491604
   PubMed Web of Science ®Google Scholar
• TanYTTillettDJMcKayIAMolecular strategies for overcoming antibiotic resistance in bacteriaMol Med Today200068309314 Swedish10904248
   PubMedGoogle Scholar
• DeydeVMXuXBrightRASurveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwideJ Infect Dis20071962249257 French17570112
   PubMed Web of Science ®Google Scholar
• Centers of Disease Control and PreventionActive Bacterial Core Surveillance (ABCs) Report: Emerging Infections Program Network, Streptococcus pneumoniae, 2007Atlanta, GACenters for Disease Control and Prevention2008 Available from: http://www.cdc.gov/abcs/reports-findings/survreports/spneu07.pdfAccessed April 16, 2013
   Google Scholar
• LaurichesseHGrimaudOWaightPJohnsonAPGeorgeRCMillerEPneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995Commun Dis Public Health19981122279718833
   PubMedGoogle Scholar
• Council of State and Territorial EpidemiologistsNational Surveillance for Drug-Resistant Streptococcus Pneumoniae (DRSP) Invasive Disease. CSTE Position Statement 1994–10Atlanta, GACouncil of State and Territorial Epidemiologists1994
   Google Scholar
• Centers for Disease Control and Prevention2007Extensively drug resistant tuberculosis – United States, 1993–2006Morb Mortal Wkly Rep56250253
   PubMedGoogle Scholar
• World Health OrganizationWorld malaria situation in 1994. Part I. Population at riskWkly Epidemiol Rec199772362692749293226
   PubMedGoogle Scholar
• GuinovartCNaviaMMTannerMAlonsoPLMalaria: burden of diseaseCurr Mol Med20066213714016515506
   PubMed Web of Science ®Google Scholar
• ArguinPMKozarskyPEReedCCenters for Disease Control and PreventionCDC Health Information for International Travel 2008St Louis, MOMosby2007
   Google Scholar
• BjorkmanAPhillips-HowardPAThe epidemiology of drug-resistant malariaTrans R Soc Trop Med Hyg19908421771802202097
   PubMed Web of Science ®Google Scholar
• KrogstadDJMalaria as a reemerging diseaseEpidemiol Rev199618177898877332
   PubMed Web of Science ®Google Scholar
• PetoHMPrattRHHarringtonTALoBuePAArmstrongLREpidemiology of extrapulmonary tuberculosis in the United States, 1993–2006Clin Infect Dis200949913501357 Swedish19793000
   PubMed Web of Science ®Google Scholar
• WangFDChenYYChenTLLiuCYRisk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremiaAm J Infect Control200836211812218313513
   PubMed Web of Science ®Google Scholar
• FeldmanCKlugmanKPneumococcal infectionsCurr Opin Infect Dis1997102109115
   Web of Science ®Google Scholar
• DowsonCGCoffeyTJSprattBGOrigin and molecular epidemiology of penicillin-binding-protein-mediated resistance to β-lactam antibioticsTrends Microbiol19942103613667850202
   PubMedGoogle Scholar
• IpMLyonDJYungRWTsangLChengAFIntroduction of new clones of penicillin-nonsusceptible Streptococcus pneumoniae in Hong KongJ Clin Microbiol20024041522152511923387
   PubMed Web of Science ®Google Scholar
• DoernGVPfallerMAKuglerKFreemanJJonesRNPrevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance programClin Infect Dis19982747647709798031
   PubMed Web of Science ®Google Scholar
• HiramatsuKAritakaNHanakiHDissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinLancet1997350909216701673 Finnish9400512
   PubMed Web of Science ®Google Scholar
• EliopoulosGMAntibiotic resistance in Enterococcus species: an updateCurr Clin Top Infect Dis19961621518714247
   PubMedGoogle Scholar
• StorchGAKrogstadDJAntibiotic-induced lysis of enterococciJ Clin Invest19816836396456792220
   PubMed Web of Science ®Google Scholar
• KrogstadDJKorfhagenTRMoelleringRCJrWennerstenCSwartzMNAminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergismJ Clin Invest197862248048697312
   PubMed Web of Science ®Google Scholar
• MoelleringRCJrKorzeniowskiOMSandeMAWennerstenCBSpecies-specific resistance to antimicrobial synergism in Streptococcus faecium and Streptococcus faecalisJ Infect Dis19791402203208 Swedish113469
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionNosocomial enterococci resistant to vancomycin – United States, 1989–1993MMWR Morb Mortal Wkly Rep199342305975998336690
   PubMedGoogle Scholar
• KlevensRMMorrisonMANadleJInvasive methicillin-resistant Staphylococcus aureus infections in the United StatesJAMA20072981517631771 French17940231
   PubMed Web of Science ®Google Scholar
• HartmanBJTomaszALow-affinity penicillin-binding protein associated with β-lactam resistance in Staphylococcus aureusJ Bacteriol198415825135166563036
   PubMed Web of Science ®Google Scholar
• McDougalLKThornsberryCThe role of β-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporinsJ Clin Microbiol19862358328393011847
   PubMed Web of Science ®Google Scholar
• LivermoreDMMultiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?Clin Infect Dis200234563464011823954
   PubMed Web of Science ®Google Scholar
• AndesDCraigWACephalosporinsMandellGLBennettJEDolinRPrinciples and Practice of Infectious DiseasesPhiladelphia, PAElsevier2005294311 French
   Google Scholar
• ShahAAHasanFAhmedSHameedACharacteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum β-lactamasesRes Microbiol2004155640942115249058
   PubMed Web of Science ®Google Scholar
• HelfandMSBonomoRAB-lactamases: a survey of protein diversityCurr Drug Targets Infect Disord20033192312570729
   PubMedGoogle Scholar
• MatthewMPlasmid-mediated β-lactamases of Gram-negative bacteria: properties and distributionJ Antimicrob Chemother197954349358385575
   PubMed Web of Science ®Google Scholar
• PerilliMSegatoreBde MassisMRTEM-72, a new extended-spectrum β-lactamase detected in Proteus mirabilis and Morganella morganii in ItalyAntimicrob Agents Chemother20004492537253910952610
   PubMed Web of Science ®Google Scholar
• RosenauACattierBGoussetNHarriauPPhilipponAQuentinRCapnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 β-lactamase in the phylum Flavobacter-bacteroidesAntimicrob Agents Chemother200044376076210681352
   PubMed Web of Science ®Google Scholar
• RoyCFozASeguraCTiradoMFosterCReigRPlasmid-determined β-lactamases identified in a group of 204 ampicillin-resistant EnterobacteriaceaeJ Antimicrob Chemother19831255075106608515
   PubMed Web of Science ®Google Scholar
• DattaNKontomichalouPPenicillinase synthesis controlled by infectious R factors in EnterobacteriaceaeNature196520850072392415326330
   PubMed Web of Science ®Google Scholar
• SirotDSirotJLabiaRTransferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamaseJ Antimicrob Chemother1987203323334 Finnish3316146
   PubMed Web of Science ®Google Scholar
• De ChampsCSauvantMPChanalCProspective survey of colonization and infection caused by expanded-spectrum-β-lactamase-producing members of the family Enterobacteriaceae in an intensive care unitJ Clin Microbiol1989271228872890 French2592552
   PubMed Web of Science ®Google Scholar
• ChambersHFOther β-lactam antibioticsMandellGLBennettJEDolinRPrinciples and Practice of Infectious DiseasesPhiladelphia, PAElsevier2005311318
   Google Scholar
• LivermoreDMWoodfordNThe β-lactamase threat in Enterobacteriaceae, Pseudomonas and AcinetobacterTrends Microbiol20064941342016876996
   PubMed Web of Science ®Google Scholar
• RuizJMechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protectionJ Antimicrob Chemother20035151109111712697644
   PubMed Web of Science ®Google Scholar
• BurmanLGApparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteriaJ Antimicrob Chemother197735509516332684
   PubMed Web of Science ®Google Scholar
• MunshiMHSackDAHaiderKAhmedZURahamanMMMorshedMGPlasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1Lancet1987285564194212887725
   PubMed Web of Science ®Google Scholar
• Martinez-MartinezLPascualAJacobyGAQuinolone resistance from a transferable plasmidLancet199835191057977999519952
   PubMed Web of Science ®Google Scholar
• DrlicaKZhaoXDNA gyrase, topoisomerase IV, and the 4-quinolonesMicrobiol Mol Biol Rev19976133773929293187
   PubMed Web of Science ®Google Scholar
• DeguchiTYasudaMNakanoMQuinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the gyrA subunit of DNA gyrase and the parC subunit of topoisomerase IV with antimicrobial susceptibility profilesAntimicrob Agents Chemother1996404102010238849219
   PubMed Web of Science ®Google Scholar
• GeorgiouMMunozRRomanFCiprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of gyrA and parCAntimicrob Agents Chemother199640717411744 French8807076
   PubMed Web of Science ®Google Scholar
• HorowitzDSWangJCMapping the active site tyrosine of Escherichia coli DNA gyraseJ Biol Chem198726211533953443031051
   PubMed Web of Science ®Google Scholar
• Moniot-VilleNGuibertJMoreauNAcarJFCollatzEGutmannLMechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acidAntimicrob Agents Chemother19913535195232039202
   PubMed Web of Science ®Google Scholar
• ConradSOethingerMKaifelKKlotzGMarreRKernWVGyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coliJ Antimicrob Chemother19963834434558889719
   PubMed Web of Science ®Google Scholar
• HeisigPTschornyRCharacterization of fluoroquinolone-resistant mutants of Escherichia coli selected in vitroAntimicrob Agents Chemother1994386128412918092826
   PubMed Web of Science ®Google Scholar
• VilaJRuizJMarcoFAssociation between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICsAntimicrob Agents Chemother1994381024772479 Portuguese7840592
   PubMed Web of Science ®Google Scholar
• TankovicJPerichonBDuvalJCourvalinPContribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitroAntimicrob Agents Chemother19964011250525108913454
   PubMed Web of Science ®Google Scholar
• WangYHuangWMTaylorDECloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutationsAntimicrob Agents Chemother19933734574638384814
   PubMed Web of Science ®Google Scholar
• HooperDCMechanisms of action and resistance of older and newer fluoroquinolonesClin Infect Dis200031Suppl 2S24S2810984324
   PubMed Web of Science ®Google Scholar
• HawkeyPMMechanisms of quinolone action and microbial responseJ Antimicrob Chemother200351Suppl 1293512702701
   PubMed Web of Science ®Google Scholar
• HooperDCMechanisms of fluoroquinolone resistanceDrug Resist Updat199921385511504468
   PubMed Web of Science ®Google Scholar
• AcarJFGoldsteinFWTrends in bacterial resistance to fluoroquinolonesClin Infect Dis199724Suppl 1S67S738994781
   PubMed Web of Science ®Google Scholar
• ChambersHFSandeMAAntimicrobial agents: the aminoglycosidesHardmanJGLimbirdLEThe Pharmacological Basis of TherapeuticsNew York, NYMcGraw-Hill199511031121
   Google Scholar
• KarlowskyJAHobanDJZelenitskySAZhanelGGAltered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosaJ Antimicrob Chemother19974033713769338489
   PubMed Web of Science ®Google Scholar
• XiongYQCaillonJKerguerisMFAdaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis modelAntimicrob Agents Chemother1997414823826 French9087497
   PubMed Web of Science ®Google Scholar
• KucersACroweSGraysonMLHoyJThe Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, and Antiviral DrugsOxfordButterworth-Heinemann1997
   Google Scholar
• DaviesJWrightGDBacterial resistance to aminoglycoside antibioticsTrends Microbiol199752342409211644
   PubMed Web of Science ®Google Scholar
• GilbertDAminoglycosidesMandellGLBennettJEDolinRPrinciples and Practice of Infectious DiseasesPhiladelphia, PAElsevier2000307355
   Google Scholar
• National Nosocomial Infections Surveillance SystemNational Nosocomial Infections Surveillance (NNIS) System Report, data summary from Jan 1992 through Jun 2004, issued Oct 2004Am J Infect Control2004328470185 French15573054
   PubMed Web of Science ®Google Scholar
• RahalJJUrbanCSegal-MaurerSNosocomial antibiotic resistance in multiple Gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sitesClin Infect Dis200234449950311797177
   PubMed Web of Science ®Google Scholar
• ManikalVMLandmanDSaurinaGOydnaELalHQualeJEndemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usageClin Infect Dis200031110110610913404
   PubMed Web of Science ®Google Scholar
• BlumbergHMBurmanWJChaissonREAmerican Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosisAm J Respir Crit Care Med20031674603662 French12588714
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAnti-Tuberculosis Drug Resistance in the WorldGenevaWorld Health Organization2008 Available from: http://whqlibdoc.who.int/hq/2008/WHO_HTM_TB_2008.394_eng.pdfAccessed April 16, 2013
   Google Scholar
• Centers for Disease Control and PreventionEmergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs – worldwide, 2000–2004MMWR Morb Mortal Wkly Rep2006551130130516557213
   PubMedGoogle Scholar
• ShimaoTDrug resistance in tuberculosis controlTubercle198768Suppl 25183120383
   PubMedGoogle Scholar
• World Health OrganizationTB: A Global Emergency. WHO Report on the TB EpidemicGenevaWorld Health Organization1994 Available from: http://whqlibdoc.who.int/hq/1994/WHO_TB_94.177.pdfAccessed April 16, 2013
   Google Scholar
• SchatzABugleEWaksmanSAStreptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteriaExp Biol Med19445516669 Italian
   Google Scholar
• LehmannJPara-aminosalicylic acid in the treatment of tuberculosisLancet1946163841521008766
   PubMed Web of Science ®Google Scholar
• BlochABSimonePMMcCrayECastroKGPreventing multidrug-resistant tuberculosisJAMA19962756487489 Italian8627974
   PubMed Web of Science ®Google Scholar
• FriedenTRSterlingTRMunsiffSSWattCJDyeCTuberculosisLancet2003362938788789913678977
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionPrevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendationsMMWR Recomm Rep199847RR–20158
   Google Scholar
• Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, Jul 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), Sep 1999, and the sections of this statementAm J Respir Crit Care Med20001614 Pt 2S221S24710764341
   PubMed Web of Science ®Google Scholar
• BowlerPGWelsbySTowersVMultidrug-resistant organisms, wounds and topical antimicrobial protectionInt Wound J20129438739622640181
   PubMed Web of Science ®Google Scholar
• KumarASchweizerHPBacterial resistance to antibiotics: active efflux and reduced uptakeAdv Drug Deliv Rev200557101486151315939505
   PubMed Web of Science ®Google Scholar
• WrightGDSutherlandADNew strategies for combating multidrug-resistant bacteriaTrends Mol Med200713626026717493872
   PubMed Web of Science ®Google Scholar
• NeuHCThe crisis in antibiotic resistanceScience19922575073106410731509257
   PubMed Web of Science ®Google Scholar
• WaxRGLewisKSalyersAATaberHBacterial Resistance to AntimicrobialsBoca Raton, FLCRC Press2008
   Google Scholar
• BoichevaMLazarovaGRachkovaKRukanovaDTenevaMDzenevaHBacterial pathogens with multidrug resistance. Etiological structure of infections in ICU, Umbal-Ead Stara ZagoraTrakia Journal of Sciences20108Suppl 2165170
   Google Scholar
• NikaidoHMultidrug resistance in bacteriaAnnu Rev Biochem200978119146 Italian19231985
   PubMed Web of Science ®Google Scholar
• SiegelJDRhinehartEJacksonMChiarelloLManagement of multidrug-resistant organisms in health care settings, 2006Am J Infect Control20073510 Suppl 2S165S19318068814
   PubMed Web of Science ®Google Scholar
• AlekshunMNLevySBMolecular mechanisms of antibacterial multidrug resistanceCell200712861037105017382878
   PubMed Web of Science ®Google Scholar
• Amato-GauciAAmmonAThe First European Communicable Disease Epidemiological ReportStockholmEuropean Centre for Disease Prevention and Control2007 Available from: http://www.ecdc.europa.eu/en/publications/Publications/0706_SUR_First_%20Annual_Epidemiological_Report_2007.pdfAccessed April 16, 2013
   Google Scholar
• Freire-MoranLAronssonBManzCCritical shortage of new antibiotics in development against multidrug-resistant bacteria – time to react is nowDrug Resist Updat201114211812421435939
   PubMed Web of Science ®Google Scholar
• ZaidiAKHuskinsWCThaverDBhuttaZAAbbasZGoldmannDAHospital-acquired neonatal infections in developing countriesLancet2005365946511751188 German15794973
   PubMed Web of Science ®Google Scholar
• Committee on New Directions in the Study of Antimicrobial TherapeuticsTreating Infectious Diseases in a Microbial World: Report of Two Workshops on Novel Antimicrobial TherapeuticsWashington, DCNational Academies Press2006
   Google Scholar
• GootzTDDiscovery and development of new antimicrobial agentsClin Microbiol Rev19903113312404566
   PubMed Web of Science ®Google Scholar
• AkyarISearching for Antibiotics Against Super Bug BacteriaAcibadem University Health Sciences Journal2010126267
   Google Scholar
• CoatesAHuYBaxRPageCThe future challenges facing the development of new antimicrobial drugsNat Rev Drug Discov200211189591012415249
   PubMed Web of Science ®Google Scholar
• PearsonH“Superbug” hurdles key drug barrierNature2002418689746912152043
   PubMed Web of Science ®Google Scholar
• BarrettJFMRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistanceExpert Opin Ther Targets20048651551915584858
   PubMed Web of Science ®Google Scholar
• SalgadoCDFarrBMCalfeeDPCommunity-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factorsClin Infect Dis2003362131139 Portuguese12522744
   PubMed Web of Science ®Google Scholar
• DeshpandeLMFritscheTRMoetGJBiedenbachDJJonesRNAntimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance programDiagn Microbiol Infect Dis2007658216317017368801
   PubMed Web of Science ®Google Scholar
• GordonKABiedenbachDJJonesRNComparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance ProgramDiagn Microbiol Infect Dis200346428528912944021
   PubMed Web of Science ®Google Scholar
• WhitneyCGFarleyMMHadlerJIncreasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United StatesN Engl J Med2000343261917192411136262
   PubMed Web of Science ®Google Scholar
• TalbotGHBradleyJEdwardsJEJrGilbertDScheldMBartlettJGBad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of AmericaClin Infect Dis200642565766816447111
   PubMed Web of Science ®Google Scholar
• JiYZhangBVanSFIdentification of critical staphylococcal genes using conditional phenotypes generated by antisense RNAScience2001293553822662269 Dutch11567142
   PubMed Web of Science ®Google Scholar
• HutchisonCAPetersonSNGillSRGlobal transposon mutagenesis and a minimal Mycoplasma genomeScience199928654472165216910591650
   PubMed Web of Science ®Google Scholar
• AkerleyBJRubinEJNovickVLAmayaKJudsonNMekalanosJJA genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzaeProc Natl Acad Sci U S A200299296697111805338
   PubMed Web of Science ®Google Scholar
• ForsythRAHaselbeckRJOhlsenKLA genome-wide strategy for the identification of essential genes in Staphylococcus aureusMol Microbiol20024361387140011952893
   PubMed Web of Science ®Google Scholar
• KobayashiKEhrlichSAlbertiniAEssential Bacillus subtilis genesProc Natl Acad Sci U S A2003100846784683 Italian12682299
   PubMed Web of Science ®Google Scholar
• YoungKJayasuriyaHOndeykaJGDiscovery of FabH/FabF inhibitors from natural productsAntimicrob Agents Chemother200650251952616436705
   PubMed Web of Science ®Google Scholar
• WangJSoissonSMYoungKPlatensimycin is a selective FabF inhibitor with potent antibiotic propertiesNature2006441709135836116710421
   PubMed Web of Science ®Google Scholar
• SinghSBJayasuriyaHOndeykaJGIsolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategyJ Am Chem Soc200612836119161192016953632
   PubMed Web of Science ®Google Scholar
• SinghSBHerathKBWangJTsouNBallRGChemistry of platensimycinTetrahedron Lett20074854295433
   Web of Science ®Google Scholar
• HerathKBAttygalleABSinghSBBiosynthetic studies of platensimycinJ Am Chem Soc200712950154221542318034483
   PubMed Web of Science ®Google Scholar
• ArnaudCAntibiotic halts lipid synthesisChem Eng News2006847
   Web of Science ®Google Scholar
• WangJKodaliSLeeSHDiscovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic propertiesProc Natl Acad Sci2007104187612761617456595
   PubMed Web of Science ®Google Scholar
• BartonSNew antibiotic on the horizon?Nat Rev Drug Discov20065539539
   Web of Science ®Google Scholar
• SinghSBYoungKNew antibiotic structures from fermentationsExpert Opin Ther Pat2010201359137120653459
   PubMed Web of Science ®Google Scholar
• HabichDvon NussbaumFPlatensimycin, a new antibiotic and “superbug challenger” from natureChem Med Chem20061995195416952137
   PubMed Web of Science ®Google Scholar
• NicolaouKCStepanAFListerTDesign, synthesis, and biological evaluation of platensimycin analogues with varying degrees of molecular complexityJ Am Chem Soc200813039131101311918771264
   PubMed Web of Science ®Google Scholar
• HolzgrabeUDingermannTZundorfIAn old pathway to new antibiotics – platensimycin. Alte wege zu neuen antibiotika – platensimycinPharm Unserer Zeit2006355388389 German17009781
   PubMedGoogle Scholar
• PriceACChoiKHHeathRJLiZWhiteSWRockCOInhibition of β-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanismJ Biol Chem200127696551655911050088
   PubMed Web of Science ®Google Scholar
• NicolaouKCLiAEdmondsDJTotal synthesis of platensimycinAngew Chem Int Ed Engl200645427086709017013803
   PubMed Web of Science ®Google Scholar
• KaliappanKPRavikumarVAn expedient enantioselective strategy for the oxatetracyclic core of platensimycinOrg Lett20079122417241917489601
   PubMed Web of Science ®Google Scholar
• ZouYChenCHTaylorCDFoxmanBMSniderBBFormal synthesis of (+/−)-platensimycinOrg Lett2007991825182817407302
   PubMed Web of Science ®Google Scholar
• LiPPayetteJNYamamotoHEnantioselective route to platensimycin: an intramolecular Robinson annulation approachJ Am Chem Soc2007129319534953517630748
   PubMed Web of Science ®Google Scholar
• NicolaouKCListerTDentonRMMonteroAEdmondsDJAdamantaplatensimycin: a bioactive analogue of platensimycinAngew Chem Int Ed Engl200746254712471417514775
   PubMed Web of Science ®Google Scholar
• PoteraCNovel pentacyclic from soils blocks bacterial fatty acid synthesisMicrobe20061350351
   Google Scholar
• ManallackDCrosbyIKhakhamYCapuanoBPlatensimycin: a promising antimicrobial targeting fatty acid synthesisCurr Med Chem200815770571018336284
   PubMed Web of Science ®Google Scholar
• JayasuriyaHHerathKBZhangCIsolation and structure of platencin: a FabH and FabF dual inhibitor with potent broad-spectrum antibiotic activityAngew Chem Int Ed Engl200746254684468817487925
   PubMed Web of Science ®Google Scholar
• PearsonHAntibiotic faces uncertain futureNature2006441709126026116710378
   PubMed Web of Science ®Google Scholar
• ChanDIVogelHJCurrent understanding of fatty acid biosynthesis and the acyl carrier proteinBiochem J2010430111920662770
   PubMed Web of Science ®Google Scholar
• HeathRJWhiteSWRockCOLipid biosynthesis as a target for antibacterial agentsProg Lipid Res200140646749711591436
   PubMed Web of Science ®Google Scholar
• CampbellJWCronanJEJrBacterial fatty acid biosynthesis: targets for antibacterial drug discoveryAnnu Rev Microbiol20015530533211544358
   PubMed Web of Science ®Google Scholar
• MiyakawaSSuzukiKNotoTHaradaYOkazakiHThiolactomycin, a new antibiotic. IV Biological properties and chemotherapeutic activity in miceJ Antibiot (Tokyo)19823544114197096196
   PubMed Web of Science ®Google Scholar
• HolfordNHSheinerLBKinetics of pharmacologic responsePharmacol Ther19821621431666752972
   PubMed Web of Science ®Google Scholar
• JangKPKimCHNaSW7-phenylplatensimycin and 11-methyl-7-phenylplatensimycin: more potent analogs of platensimycinBioorg Med Chem Lett20102072156215820207542
   PubMed Web of Science ®Google Scholar
• BarykinaOVRossiKLRybakMJSniderBBSynthesis and antibacterial properties of (−)-nor-platencinOrg Lett200911225334533719845392
   PubMed Web of Science ®Google Scholar
• PatraMGasserGWenzelMMerzKBandowJEMetzler-NolteNSynthesis and biological evaluation of ferrocene-containing bioorganometallics inspired by the antibiotic platensimycin lead structureOrganometallics20102943124319
   Web of Science ®Google Scholar
• WangJLeeVSintimHOEfforts towards the identification of simpler platensimycin analogues – the total synthesis of oxazinidinyl platensimycinChemistry200915122747275019212990
   PubMed Web of Science ®Google Scholar
• WangJSintimHODialkylamino-2,4-dihydroxybenzoic acids as easily synthesized analogues of platensimycin and platencin with comparable antibacterial propertiesChemistry201117123352335721322068
   PubMed Web of Science ®Google Scholar
• CohenRApproaches to reduce antibiotic resistance in the communityPediatr Infect Dis J2006251097798017006310
   PubMed Web of Science ®Google Scholar
• PalanichamyKKaliappanKPDiscovery and syntheses of “superbug challengers” – platensimycin and platencinChem Asian J20105466870320209576
   PubMed Web of Science ®Google Scholar
• SilverLLChallenges of antibacterial discoveryClin Microbiol Rev20112417110921233508
   PubMed Web of Science ®Google Scholar
• BrownAKTaylorRCBhattAFuttererKBesraGSPlatensimycin activity against mycobacterial β-ketoacyl-ACP synthasesPLoS One200947e630619609444
   PubMed Web of Science ®Google Scholar
• NicolaouKCTriaGSEdmondsDJTotal synthesis of platencinAngew Chem Int Ed Engl20084791780178318246566
   PubMed Web of Science ®Google Scholar
• HayashidaJRawalVHTotal synthesis of (+/–)-platencinAngew Chem Int Ed Engl200847234373437618454442
   PubMed Web of Science ®Google Scholar
• TiefenbacherKMulzerJSynthesis of platensimycin. Synthese von platensimycinAngew Chem20081201425822590 German
   Google Scholar
• YunSYZhengJCLeeDConcise synthesis of the tricyclic core of platencinAngew Chem Int Ed Engl200847336201620318548466
   PubMed Web of Science ®Google Scholar
• WaalboerDCJSchaapmanMCvan DelftFLRutjesFPHigh-pressure entry into platencinAngew Chem Int Ed Engl200847356576657818666193
   PubMed Web of Science ®Google Scholar
• NicolaouKCTohQYChenDYAn expedient asymmetric synthesis of platencinJ Am Chem Soc200813034112921129318665593
   PubMed Web of Science ®Google Scholar
• AustinKABanwellMGWillisACA formal total synthesis of platencinOrg Lett200810204465446818798641
   PubMed Web of Science ®Google Scholar
• JayasuriyaHHerathKBOndeykaJGStructure of homoplatensimide A: a potential key biosynthetic intermediate of platensimycin isolated from Streptomyces platensisTetrahedron Lett2008492236483651
   Web of Science ®Google Scholar
• HerathKBZhangCJayasuriyaHStructure and semisynthesis of platensimide A, produced by Streptomyces platensisOrg Lett20081091699170218393511
   PubMed Web of Science ®Google Scholar
• ZhangCOndeykaJZinkDLBurgessBWangJSinghSBIsolation, structure and fatty acid synthesis inhibitory activities of platensimycin B1–B3 from Streptomyces platensisChem Commun (Camb)2008405034503618931777
   PubMed Web of Science ®Google Scholar
• SinghSBJayasuriyaHHerathKBIsolation, enzyme-bound structure, and activity of platensimycin A1 from Streptomyces platensisTetrahedron Lett2009503751825185
   Web of Science ®Google Scholar
• WuMSinghSBWangJAntidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetesProc Natl Acad Sci U S A2011108135378538321389266
   PubMed Web of Science ®Google Scholar
• SkoldOAntibiotics and Antibiotic ResistanceHoboken, NJJohn Wiley & Sons2011
   Google Scholar